These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 29754700)
1. HPV single-dose vaccination: Impact potential, evidence base and further evaluation. Stanley M; Dull P Vaccine; 2018 Aug; 36(32 Pt A):4759-4760. PubMed ID: 29754700 [No Abstract] [Full Text] [Related]
2. Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study. Sankaranarayanan R; Joshi S; Muwonge R; Esmy PO; Basu P; Prabhu P; Bhatla N; Nene BM; Shaw J; Poli URR; Verma Y; Zomawia E; Pimple S; Tommasino M; Pawlita M; Gheit T; Waterboer T; Sehr P; Pillai MR; Vaccine; 2018 Aug; 36(32 Pt A):4783-4791. PubMed ID: 29551226 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of AS04-adjuvanted human papillomavirus 16/18 vaccine compared with human papillomavirus 6/11/16/18 vaccine in the Philippines, with the new 2-dose schedule. Germar MJ; Purugganan C; Bernardino MS; Cuenca B; Chen YC; Li X; Van Kriekinge G; Lee IH Hum Vaccin Immunother; 2017 May; 13(5):1158-1166. PubMed ID: 28075249 [TBL] [Abstract][Full Text] [Related]
4. Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines. Van Damme P; Bonanni P; Bosch FX; Joura E; Kjaer SK; Meijer CJ; Petry KU; Soubeyrand B; Verstraeten T; Stanley M Vaccine; 2016 Feb; 34(6):757-61. PubMed ID: 26772631 [TBL] [Abstract][Full Text] [Related]
5. HPV vaccination: too soon for 2 doses? Kahn JA; Bernstein DI JAMA; 2013 May; 309(17):1832-4. PubMed ID: 23632729 [No Abstract] [Full Text] [Related]
6. Human papillomavirus quadrivalent vaccine: a look behind the numbers. Flaherty DK; Alkhateeb FM Ann Pharmacother; 2009 Apr; 43(4):740-4. PubMed ID: 19276314 [TBL] [Abstract][Full Text] [Related]
7. Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country. Burger EA; Campos NG; Sy S; Regan C; Kim JJ Vaccine; 2018 Aug; 36(32 Pt A):4823-4829. PubMed ID: 29807710 [TBL] [Abstract][Full Text] [Related]
8. [Cervical carcinoma and the vaccination experience with Cervarix]. Berberova M Akush Ginekol (Sofiia); 2012; 51 Suppl 1():4-5. PubMed ID: 23236670 [No Abstract] [Full Text] [Related]
9. Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies. Kreimer AR; Herrero R; Sampson JN; Porras C; Lowy DR; Schiller JT; Schiffman M; Rodriguez AC; Chanock S; Jimenez S; Schussler J; Gail MH; Safaeian M; Kemp TJ; Cortes B; Pinto LA; Hildesheim A; Gonzalez P; Vaccine; 2018 Aug; 36(32 Pt A):4774-4782. PubMed ID: 29366703 [TBL] [Abstract][Full Text] [Related]
10. Gynaecological cancer: HPV vaccine: is age just a number? Stone L Nat Rev Urol; 2014 Nov; 11(11):605. PubMed ID: 25245243 [No Abstract] [Full Text] [Related]
11. [Vaccination against HPV in adults]. Gil Á Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():22-5. PubMed ID: 20084345 [No Abstract] [Full Text] [Related]
12. Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study. Basu P; Malvi SG; Joshi S; Bhatla N; Muwonge R; Lucas E; Verma Y; Esmy PO; Poli URR; Shah A; Zomawia E; Pimple S; Jayant K; Hingmire S; Chiwate A; Divate U; Vashist S; Mishra G; Jadhav R; Siddiqi M; Sankaran S; Prabhu PR; Kannan TPRA; Varghese R; Shastri SS; Anantharaman D; Gheit T; Tommasino M; Sauvaget C; Pillai MR; Sankaranarayanan R Lancet Oncol; 2021 Nov; 22(11):1518-1529. PubMed ID: 34634254 [TBL] [Abstract][Full Text] [Related]
13. Studies Find Single Dose of HPV Vaccines May Be Effective. Larkin HD JAMA; 2022 Nov; 328(19):1896. PubMed ID: 36378200 [No Abstract] [Full Text] [Related]
14. NIH lab helps get vaccine from bench to bedside. Traynor K Am J Health Syst Pharm; 2007 Mar; 64(5):452. PubMed ID: 17322152 [No Abstract] [Full Text] [Related]
15. Persistence of Immunity When Using Different Human Papillomavirus Vaccination Schedules and Booster-Dose Effects 5 Years After Primary Vaccination. Lazcano-Ponce E; Torres-Ibarra L; Cruz-Valdez A; Salmerón J; Barrientos-Gutiérrez T; Prado-Galbarro J; Stanley M; Muñoz N; Herrero R; Hernández-Ávila M J Infect Dis; 2019 Jan; 219(1):41-49. PubMed ID: 30085139 [TBL] [Abstract][Full Text] [Related]
16. The efficacy of HPV 16/18 vaccines on sexually active 18-23 year old women and the impact of HPV vaccination on organized cervical cancer screening. Sigurdsson K; Sigvaldason H; Gudmundsdottir T; Sigurdsson R; Briem H Acta Obstet Gynecol Scand; 2009; 88(1):27-35. PubMed ID: 19031282 [TBL] [Abstract][Full Text] [Related]
18. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm]. Delvenne P Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390 [TBL] [Abstract][Full Text] [Related]
19. Explanations for the high potency of HPV prophylactic vaccines. Schiller J; Lowy D Vaccine; 2018 Aug; 36(32 Pt A):4768-4773. PubMed ID: 29325819 [TBL] [Abstract][Full Text] [Related]
20. Issues in human papillomavirus vaccination in adolescents. Moscicki AB; Smith JS J Adolesc Health; 2008 Oct; 43(4 Suppl):S1-4. PubMed ID: 18809142 [No Abstract] [Full Text] [Related] [Next] [New Search]